The Allspring Asset Allocation Fund outperformed its benchmark in Q1 2026 despite market volatility. Read the full analysis ...

May, but it has since begun to follow the oil price downward and last week generated evidence of an intermediate-term top ...

Edgewise Therapeutics (EWTX) stays a Buy after its $2.65B Servier deal funds EDG-7500 for HCM with key Q2 2026 data. Read ...

Nomura Climate Solutions Fund outperformed its benchmark in Q1 2026, driven by strategic sector allocation. Read the full ...

Chevron upgraded to Strong Buy: robust production growth, limited Middle East risk, solid Q1 results, and undervalued shares ...

UnitedHealth (UNH) is re-rated to Hold after a sharp rally and valuation expansion post-FQ1 2026. Read here for a detailed ...

RV sales, backlog, and margins fell; cash flow turned negative, and EPS guidance was cut. Read here for an analysis of THO ...

Replimune (REPL) faces a binary FDA decision on RP1 in advanced melanoma. RP1 approval could push REPL to $14.99/share. See ...

Air Liquide stock remains a buy as margins expand and a €5.5B backlog supports growth. The October Capital Market Day is a ...

Truist Financial (TFC) outlook: buybacks, surplus capital, and a 4%+ dividend support EPS growth. Read here for a detailed ...

President Trump announced plans to direct ‌hundreds of millions of dollars to support US coal-fired power plants and coal ...

The Russell 2000 has outperformed the S&P 500 YTD, and earnings are expected to soar in 2026. Discover 5 top Russell 2000 ...